News by subject: TRI

Omeza®, a regenerative skincare company that develops marine-based therapies for the treatment of chronic wounds, today presented positive interim data from a diabetic foot ulcer (DFU) clinical trial showing that Omeza® OCMtm plus offloading of...

A new tuberculosis (TB) test disclosed in the Association for Diagnostics & Laboratory Medicine's (formerly AACC's) Clinical Chemistry journal would allow testing for TB treatment monitoring to occur outside of a biosafety level 3 (BSL-3) laboratory....

Genomenon, a leading genomic intelligence company, presented data at the ACMG Annual Clinical Genetics Meeting today demonstrating how computational indexing of millions of published abstracts and full-text references combined with a systematic...

Mozart Therapeutics, the leading developer of CD8 Treg modulators for the treatment of autoimmune and inflammatory diseases, today announce new non-clinical data for MTX-101. The data will be presented in a late-breaking poster presentation during...

The Prostate Cancer Foundation (PCF) today announced the 2023 Class of PCF Team Challenge Award recipients and a total of more than $21 million in funding for innovative prostate cancer research....

myTomorrows today announced a new partnership with the ALS Association, the U.S.-based nonprofit organization fighting ALS on every front. myTomorrows is a global health technology company shaping the future landscape of clinical trial accessibility...

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced the publication of a new study featuring Lunit SCOPE HER2 and Lunit SCOPE ER/PR, Lunit's AI-powered...

BIMZELX® (bimekizumab) is the first and only treatment approved by Health Canada for eligible patients with active psoriatic arthritis (PsA) or axial spondyloarthritis (axSpA) that directly and selectively inhibits two key inflammatory proteins,...

Gynica, a clinical-stage women's health biotech startup developing a novel Endometriosis treatment, announces today the submission of a...

Calder Biosciences, Inc., a next-generation vaccine company, has been published in a Nature Communications article (https://www.nature.com/articles/s41467-024-46295-8) that debuts and validates the application of Calder's '3D Vaxlock' platform...

In 2019, chronic kidney disease (CKD) was responsible for over 3.1 million deaths, ranking it the 8th leading cause of death worldwide. The global mortality attributed to all kidney diseases is estimated to range between 5 and 11 million annually,...

Prelude Corporation (PreludeDxtm), a leader in precision diagnostics, has unveiled data from an analysis of over 700 early-stage invasive breast cancer patients for AidaBreasttm - a novel biosignature that predicts 10-year recurrence rate and...

A new study has shed light on the importance of the protein STAP-1 in activating certain immune cells. Understanding the role of STAP-1 in these cells could give researchers a better glimpse into immune-related disorders and ways to treat them....

In 2019, chronic kidney disease (CKD) was responsible for over 3.1 million deaths, ranking it the 8th leading cause of death worldwide. The global mortality attributed to all kidney diseases is estimated to range between 5 and 11 million annually,...

Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939.HK), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, announces that Kintor and its cooperative partner had published an article named...

In a recent presentation to the US Biophysical Society in Philadelphia1, Asep Medical Holdings Inc. ("Asep Inc." or the "Company") CEO Dr. Bob Hancock announced how the ground-breaking use of artificial intelligence (AI) has allowed the...

Poseida Therapeutics, Inc. , a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with cancer and rare diseases, today announced the U.S. Food and Drug Administration (FDA) has granted Orphan Drug...

Radyus Research, a global drug development organization from Atlanta, Georgia, is excited to announce a pivotal strategic partnership with Southern Research, a Birmingham-based contract research organization with more than 80 years of experience in...

Encore Clinical Holdings Corp is thrilled to announce the acquisition of Primus Wound Care, marking a significant expansion in its services, and establishing itself as the largest provider of wound care in Ohio. This strategic acquisition not only...

In a significant advancement for mental health care, Madrigal Mental Care is excited to announce the successful completion of its pivotal nanotechnology research on the use of Ketamine as a treatment for trauma related disorders such as...

Conformal Medical, Inc. announced that the CLAAS® System was featured in a podium presentation at the Cardiovascular Research Technologies (CRT) 2024 conference. Dr. William Gray, Professor of Medicine, Thomas Jefferson University, System Chief,...

Today, Cedar Health Research®, a multi-therapeutic independent clinical research site and patient network, officially announced two new sites in Texas located in Arlington, TX and Midland, TX. ...

A certain variant of a key anti-inflammatory gene protects men under age 75 from severe illness and death when hospitalized from Covid-19, a genetic analysis of their blood shows....

Pulsenmore , the world leader in self-scan ultrasound technology for at-home use and remote clinical diagnosis, announces its new clinical study collaboration with Michigan Medicine. The study will examine the ability to conduct a remote biophysical...

NeuroBo Pharmaceuticals, Inc. , a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced receipt of Safety Review Committee (SRC) approval, recommending that the two-part Phase 2a trial of...

YolTech Therapeutics, a biotech company pioneering in in vivo gene editing therapies, today announced participation in TIDES Asia 2024, March 19th to 21st, 2024, at the Westin Miyako Kyoto in Kyoto, Japan. TIDES Asia, a conference in Asia that...

Expert Systems, a leader in AI-enabled drug discovery, proudly announces a significant milestone in partnership with Eilean Therapeutics LLC: the start of Phase 1 trial of balamenib (ZE63-0302), a highly selective inhibitor of the menin?KMT2A binding...

Kazia Therapeutics Limited , a biotechnology company specialising in oncology, is pleased to announce the presentation of new data for both its pipeline molecules, paxalisib and EVT801, at the upcoming Annual Meeting of the American Association of...

Ionis Pharmaceuticals, Inc. ...

Caris Life Sciences®(Caris), the leading next-generation AI TechBio company and precision medicine pioneer that is actively developing and delivering innovative solutions to revolutionize healthcare and improve the human condition...

Total operating revenues for the full year 2023 were $16.3M, compared to $15.8M for the same period in 2022.As of March 7, 2024, Ryvu's cash position was $57.2M, excluding the first tranche of ?8M in venture debt from the EIB, expected imminently....

Jeeva Clinical Trials is revolutionizing drug development by integrating AI and automated workflows into clinical trials, significantly reducing the time and cost of bringing treatments to market. Led by Dr. Harsha Rajasimha, the platform emphasizes...

The Journal of Orthopedics published the results of a study concluding that Incrediwear, the leading provider of innovative therapeutic wear, provides more benefit after total knee arthroplasty (TKA) than compression stockings or Thrombo-Embolsim...

Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced that it will present results of three preclinical studies as poster presentation at the AACR Annual Meeting to be held in San Diego, USA, from...

PacBio , a leading developer of high-quality, highly accurate sequencing solutions, today announced the PureTarget repeat expansion panel, a new solution designed to enable the comprehensive analysis of 20 genes associated with serious neurological...

Genprex, Inc. ("Genprex" or the "Company") , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that the Korean Patent Office has issued a Notice of Patent Grant...

The Job Research Foundation was established to underwrite research into Job Syndrome, also known as Autosomal Dominant Hyperimmunoglobulin E Syndrome (AD-HIES), a rare multisystem immunodeficiency disorder. The Foundation's main goal is to help...

NetraMark Holdings Inc. (the "Company" or "NetraMark")  a generative AI...

Lamassu Bio Inc., a cutting-edge biotech company dedicated to innovative cancer therapies, has been awarded a grant from the  National Institutes of Health (NIH) and National Cancer Institute ( NCI) for the development of their groundbreaking...

DarioHealth Corp. (the "Company"), a leader in the global digital therapeutics (DTx) market, announced...

BioMarin Pharmaceutical Inc. announced that positive early results from an investigator-sponsored Phase 2 study of VOXZOGO® (vosoritide) in children with hypochondroplasia, will be presented at the 2024...

 Data presented by the MS team at Hadassah Medical Center, Jerusalem, led by Prof. Dimitrios Karussis, in the Americas Committee for Treatment and Research in Multiple Sclerosis Forum reveal consistent reductions in serum levels of both NfL and GFAP,...

Longbio Pharma (Suzhou) Co., Ltd. (referred to as "Longbio Pharma"), a leading biotech company dedicated to developing innovative protein treatments for allergy, respiratory, dermatology, hematology, ophthalmology, and other autoimmune and rare...

An unprecedented achievement of a zero pressure gradient measured when using the VORTXtm device, directly correlating with a decrease in markers of blood damage.The performance of the VORTXtm, tested according to a regulatory guideline, was found to...

BrickBio.com, a pioneering leader in ADC (antibody drug conjugates) with a wide toolkit ranging from site specific chemistries to accessibility to novel payloads, proudly announces a groundbreaking achievement that has the potential to revolutionize...

Sumitomo Pharma Canada, Inc., announced today that ORGOVYX® (relugolix), an oral gonadotropin-releasing hormone (GnRH) receptor antagonist, is now available for prescription in Canada for the treatment of adult patients with advanced prostate cancer....

Collaboration combines Clario's transformative technology with Cleveland Clinic's market-leading imaging expertise and AI-enabled analysis to help bring new therapies to patients, faster. Strategic partnership helps sponsors overcome common clinical...

Emboline, Inc., a privately held medical technology company focused on reducing stroke and ischemic damage during structural heart procedures such as transcatheter aortic valve replacement (TAVR), marked a key milestone with the enrollment of the...

Regulus Therapeutics Inc. (Nasdaq:...

...